Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07147894 · ClinicalTrials.gov registry record · NA

Executive Function Training for Children and Adolescents

A NA study of Cognitive Change, sponsored by Northeastern University.

Recruiting
Registry status
NA
Development phase
780
Enrollment target
1
Study location

NCT07147894: Recruiting NA study of Cognitive Change, sponsored by Northeastern University.

NCT07147894 is a NA study of Cognitive Change that is actively recruiting participants, run by Northeastern University. The registered enrollment target is 780 participants, above the 163-participant average among 44 other Cognitive Change trials with a reported enrollment target (379% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07147894, a NA study of Cognitive Change, is actively recruiting participants, sponsored by Northeastern University.

RECRUITING
Registry status
NA
Development phase
780 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate how different approaches to executive function (like adding game-like features, varying the number of tasks, and providing coaching) can enhance executive function outcomes in adolescents with and without ADHD. The main questions it aims to answer are: * What components of executive function training contribute most to improving outcomes? * How do training components vary in their impacts on adolescents diagnosed with ADHD compared to those without a diagnosis? * What individual characteristics influence the effectiveness of executive function training? Researchers will test six different training setups to examine which setups are the most effective for different people. They will evaluate both how well participants follow the training schedule and whether there are changes in psychological and cognitive outcomes after training. Participants will complete: * 40 training sessions over 4 weeks * A set of tests and surveys before and after the training * Follow-up assessments and surveys 6 months after finishing the training

Primary Outcome

An Adherence Composite will be an aggregate score between (1) Participant compliance assessed by the number of completed training sessions completed within guidelines. For each completed training session that complies with the schedule, participants will receive one point, for a total of 40 possible points; (2) Self-reported engagement: After each training session, children are asked to rate their level of engagement using a Likert scale. The dependent variable will be the average engagement rat

Conditions Studied

Interventions

  • BEHAVIORAL Coaching Session
  • BEHAVIORAL Nongamified N-back training
  • BEHAVIORAL Gamified N-back training
  • BEHAVIORAL Multiple Domain Training

Study Locations (1)

Massachusetts

  • Northeastern University - Boston

Trial Details

FieldValue
Enrollment Target 780 participants
Start Date 2025-12-14
Est. Completion 2028-06-30
Phase NA
Northeastern University

39 total trials

What NCT07147894 shows while recruiting

NCT07147894 is an interventional study that assigns participants to a tested intervention. The registered 780 participants enrollment target is mid-sized for trials with a published cap, above the 163-participant average among 44 other Cognitive Change trials with a reported enrollment target (379% higher).

The record links to 1 condition, with Cognitive Change appearing as the primary indexed condition, and to 4 interventions - of which Coaching Session is the first listed.

NCT07147894 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07147894 about?

NCT07147894 is a clinical study titled "Executive Function Training for Children and Adolescents". The goal of this clinical trial is to evaluate how different approaches to executive function (like adding game-like features, varying the number of tasks, and providing coaching) can enhance executive function outcomes in adolescents with and without ADHD. The main questions it aims to answer are: ...

What is the current status of trial NCT07147894?

This trial is currently recruiting. It is a NA study. The enrollment target is 780 participants. The study started on 2025-12-14. Estimated completion is 2028-06-30.

What conditions does trial NCT07147894 study?

This clinical trial studies the following conditions: Cognitive Change.

What interventions are being tested in trial NCT07147894?

The interventions under investigation include: Coaching Session (BEHAVIORAL), Nongamified N-back training (BEHAVIORAL), Gamified N-back training (BEHAVIORAL), Multiple Domain Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT07147894?

This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07147894 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Change

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07147894's enrollment target sits among peer trials

780 3rd of 44 higher than 42 of 44 other Cognitive Change trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Change trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05046613 · 780 participants

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • NCT05100862 · 780 participants · Phase 3

    A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  • NCT05513872 · 780 participants · Phase 1

    Overcoming Nicotine Dependence to Enable Quitting

  • NCT06310031 · 780 participants · NA

    Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07147894, the US trial registry maintained by the National Library of Medicine. NCT07147894 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.